Search

A series of novel dual A2A/A2B AR antagonists based on the triazole-pyrimidine-methylbenzonitrile core were designed and synthesised. The A2A AR antagonist cAMP functional assay results were encouraging for most target compounds containing quinoline or its open-ring bioisosteres. In addition, compound 7i displayed better inhibitory activity on A2B AR (IC50 14.12 nM) and higher potency in IL-2 production than AB928. Moreover, molecular docking studies were carried out to explain the rationality of molecular design and the activity of compound 7i. Further studies on 7f and 7i revealed good liver microsomes stabilities and acceptable in vivo PK profiles. This study provides insight into the future development of dual A2A/A2B AR antagonists for cancer immunotherapy.

A series of novel dual A2A/A2B AR antagonists based on the triazole-pyrimidine-methylbenzonitrile core were designed and synthesised. The A2A AR antagonist cAMP functional assay results were encouraging for most target compounds containing quinoline or its open-ring bioisosteres. In addition, compound 7i displayed better inhibitory activity on A2B AR (IC50 14.12 µM) and higher potency in IL-2 production than AB928. Moreover, molecular docking studies were carried out to explain the rationality of molecular design and the activity of compound 7i. Further studies on 7f and 7i revealed good liver microsomes stabilities and acceptable in vivo PK profiles. This study provides insight into the future development of dual A2A/A2B AR antagonists for cancer immunotherapy. [ABSTRACT FROM AUTHOR]

The gas-phase enthalpies of formation of 2-, 3-, and 4-methylbenzonitrile at T = 298.15 K were studied by combustion calorimetry, and their vaporization enthalpies were determined using the transpiration method. The composite ab initio methods W1-F12 and G4 were used to calculate the gas-phase enthalpies of formation for these three methylbenzonitriles. These theoretical values were found to be in excellent agreement with the corresponding experimental data. The analysis of these data revealed that the interaction between cyano and methyl groups is slightly stabilizing. Using the experimental data a set of group-additivity terms, which allows to estimate thermochemical properties for methyl and cyano substituted benzenes, was proposed. These terms, together with theoretical data, were subsequently used to reassess the thermochemical properties of 2,6-dimethylbenzonitrile and 2,4,6-trimethylbenzonitrile. [ABSTRACT FROM AUTHOR]

A series of novel dual A 2A /A 2B AR antagonists based on the triazole-pyrimidine-methylbenzonitrile core were designed and synthesised. The A 2A AR antagonist cAMP functional assay results were encouraging for most target compounds containing quinoline or its open-ring bioisosteres. In addition, compound 7i displayed better inhibitory activity on A 2B AR (IC 50 14.12 nM) and higher potency in IL-2 production than AB928. Moreover, molecular docking studies were carried out to explain the rationality of molecular design and the activity of compound 7i . Further studies on 7f and 7i revealed good liver microsomes stabilities and acceptable in vivo PK profiles. This study provides insight into the future development of dual A 2A /A 2B AR antagonists for cancer immunotherapy.